# What is this product?
Type:
This product is a UCITS Fund, which is structured as an umbrella ICAV with segregated lability. The assets and liabilities of each sub-fund of the ICAV are segregated as a matter of Irish law with each sub-fund comprising a separate and distinct portfolio of investments, and accordingly in the event of the insolvency of a sub-fund only investors of that sub-fund will be affected. Shares in the Fund may be switched for shares of another class in the Fund or shares of another sub-fund of the ICAV (if available), subject to certain conditions and meeting the requirements for investment in such other classes or sub-funds. See the section entitled “Conversion of Shares” in the ICAV’s prospectus for further information. The Fund's assets are held through its depositary, Northern Trust Fiduciary Services (Ireland) Limited. Further information about the Fund (including the current prospectus and the latest annual and semi-annual reports, which are prepared for GQG Global UCITS ICAV as a whole), as well as information on other share classes of the Fund and other sub-funds of the ICAV available to you, is available in English, free of charge, from Northern Trust International Fund Administration Services (Ireland) Limited (the "Administrator") and at GQGpartners.com.
Term:
This Fund is an open-ended UCITS and has an indefinite duration. The Fund may be terminated at any time in line with the constitutional documents of the ICAV.
Objectives:
The Fund’s investment objective is to seek long term capital appreciation.
The Fund may invest in Equity and ELS, including common stock, preferred stock and options, of U.S. companies. The Fund also may invest in equity securities of non-U.S. companies in both developed and Emerging Markets. This Fund has no limitation on the capitalization size or industry focus of the companies in which it invests. The Fund may invest in initial public offerings. The ELS in which the Fund will invest include depositary receipts, which are certificates typically issued by a bank or trust company that represent ownership interests in securities of non-U.S. companies.
The Fund will exclude investments in companies that derive more than 25% of their revenue from tobacco. In addition, no investments will be made in companies associated with the production of controversial weapons such as anti-personnel mines, cluster munitions, depleted uranium and biological or chemical weapons (i.e. companies screened out by the MSCI ex-Controversial Weapons Index).
The Fund may use the following FDIs for investment purposes: participation notes or participatory notes (which do not embed leverage) and/or LEPOs to gain access to inaccessible securities.
The Fund may invest up to 20% of net assets in non-U.S. investments. The Fund may also invest in: units of other UCITS and real estate investment trusts.
For Accumulating classes, any income or gains of the Fund (net of expenses) will be accumulated and reinvested into the NAV of the Fund. For Distributing classes, any income less expenses earned will be distributed in accordance with the distribution policy in the prospectus.
For full investment objective and policy details, please refer to the “Investment Objective” and “Investment Policies” sections of the Fund’s supplement.
Investors can buy or sell shares on any day on which banks are open for business in Dublin and London.
Recommendation: This Fund is not suitable for investors unable to maintain a long term investment.
Equities: securities representing an equity instrument in a company.
ELS: equity linked securities such as depositary receipts, participatory notes and LEPOs.
Emerging Markets: every country except the U.S., Canada, Japan, Australia, New Zealand, and most of the countries in Western Europe.
LEPOs: Low Exercise Price Options, an FDI where the price to exercise the option to buy/sell the underlying asset is close to zero.
FDIs: a derivative contract between two or more parties whose value depends on the rise and fall of the relative value/price of an underlying asset.
NAV: net asset value of the Fund.
Intended retail investor:
An investment in the Fund is suitable for investors seeking capital appreciation and that are prepared to accept a moderate to high level of volatility. As with any investment in emerging markets volatility will be relatively high on an absolute basis when compared with established markets, however the level of volatility is anticipated to be moderate when compared to similarly focused geographical strategies.
The Fund is intended for investors (i) with knowledge and/or experience of these types of products, (ii) that have obtained appropriate investment advice and (iii) that have the ability to bear losses up to the amount they have invested in the Fund.
Investors should be prepared to maintain a long-term investment in the Fund.
Your shares can be sold on any business day in the Fund, which is defined in the Prospectus as days when banks are open in Dublin and London.
Dividends will be reinvested into the Net Assets of the Fund for Accumulating Share Classes. Dividends may be distributed for Distribution Share Classes.

Translation (ENFR, 2023-01-01):
# En quoi consiste ce produit ?
Type :
Ce produit est un Fonds OPCVM, structuré comme un ICAV à compartiments multiples avec responsabilité séparée entre ses compartiments. Les éléments d’actif et de passif de chaque compartiment de l’ICAV sont ségrégués de ceux des autres compartiments en vertu des dispositions légales irlandaises. Chaque compartiment comprend un portefeuille d’investissements séparé et distinct et, par conséquent, en cas d’insolvabilité d’un compartiment, seuls les investisseurs du compartiment concerné seront affectés. Les actions du Fonds pourront être échangées contre des actions d’une autre catégorie du Fonds ou des actions d’un autre compartiment de l’ICAV (s’il y a lieu), sous réserve de certaines conditions et dans le respect des exigences applicables à l’investissement dans d’autres catégories ou compartiments. Veuillez lire la section du prospectus de l’ICAV intitulée
« Conversion des actions » pour de plus amples renseignements. Les actifs du Fonds sont détenus auprès de son dépositaire, Northern Trust Fiduciary Services (Ireland) Limited. De plus amples informations sur le Fonds (y compris le prospectus actuel et les derniers rapports annuel et semestriel préparés pour l’ensemble de GQG Global UCITS ICAV), ainsi que sur les autres catégories d’actions du Fonds ou les autres compartiments de l’ICAV sont disponibles en anglais, sans frais, auprès de Northern Trust International Fund Administration Services (Ireland) Limited (l’« Agent administratif ») ou sur le site GQGpartners.com.
Durée :
Le Fonds est un OPCVM à capital variable et de durée indéfinie. Le Fonds pourra être clôturé à tout moment, conformément aux documents constitutifs de l’ICAV.
Objectifs :
L’objectif d’investissement du Fonds consiste à rechercher une appréciation du capital sur le long terme.
Le Fonds pourra investir dans des actions ou titres liés à des actions, dont des actions ordinaires, des actions préférentielles et des options sur actions, de sociétés américaines. Le Fonds pourra également investir dans des actions de sociétés non américaines situées tant dans des marchés développés qu’émergents. Le Fonds n’est soumis à aucune restriction en termes de capitalisation ou de secteur eu égard aux sociétés dans lesquels il investit. Le Fonds pourra investir dans des sociétés lors de leur introduction en Bourse. Les titres liés à des actions dans lesquels le Fonds investira incluent les certificats représentatifs de titres, habituellement émis par une banque ou une société de fiducie ayant des participations dans des titres de sociétés non américaines.
Le Fonds exclura les placements dans des sociétés dont plus de 25 % des revenus proviennent du tabac. En outre, aucun placement ne sera effectué dans des sociétés qui prennent part à la production d’armes controversées comme les mines antipersonnelles, les bombes à fragmentation et les armes chimiques, biologiques ou contenant de l’uranium appauvri (à savoir des entreprises exclues par l’indice MSCI ex-Controversial Weapons Index).
Le Fonds pourra recourir aux IFD suivants à des fins de placement : bons de participation ou obligations participatives (sans effet de levier) et/ou options à bas prix d’exercice (« LEPO »). Il pourra ainsi investir dans des titres qui sont autrement inaccessibles.